When it comes to iodinated contrast reactions in children, it’s important to have a policy in place before the need arises, as well as appropriate training, equipment, and physiologic ranges, according to a presentation by Dr. Donald P. Frush at the International Symposium on Multidetector-Row CT May 19.
When it comes to iodinated contrast reactions in children, it's important to have a policy in place before the need arises, as well as appropriate training, equipment, and physiologic ranges, according to a presentation by Dr. Donald P. Frush at the International Symposium on Multidetector-Row CT May 19.
A policy should be in place beforehand regarding contrast reactions because the reactions in children are rare, unpredictable, happen quickly, and are often unheralded, according to Dr. Frush, a professor of pediatric medicine at Duke University.
Frush has been involved as a consultant in several lawsuits over children's contrast reactions that had bad outcomes.
"The problem is not so much whether the outcome is bad or good," he said. "The problem is when you don't have a policy and people just did whatever they thought was OK."
At Duke, the radiologists conducted a simulation protocol involving mannequins, and the researchers found that early intervention was critical (Radiology 2007;245:236-244). The radiologists and trainees were deficient in their ability to manage contrast reactions in children, according to Frush.
A decision-based algorithm, a sort of flow chart to help a radiologist determine the appropriate next step based on the patient's weight, age, and other factors, would aid radiologists significantly, Frush said.
Another possibility is the creation of a rapid response team. When something goes wrong, the rapid response team is activated.
"Radiologists are not the right people to be managing a kid who is starting to turn bad, and you don't want to wait until it's too late. Anybody's worried about anything -- you can call this team, and they're not punitive. They prefer to be called and told, ‘Hey everything's OK,' rather than the other way around," he said.
The rarity of contrast reactions makes it all the more important to establish a policy and to understand the nuances of the reactions, Frush said.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.